BRAF基因在结直肠癌的靶向治疗及预后判断中的作用
被引量:1
摘要
结直肠癌(CRC)是世界范围内的常见恶性肿瘤之一,目前已成为我国第4位或第5位高发的恶性肿瘤。随着我国经济的发展、人民生活水平的提高及生活方式的改变,结直肠癌的发病率也随之上升[1],严重威胁着我国人民的身体健康。
出处
《社区医学杂志》
2011年第12期39-41,共3页
Journal Of Community Medicine
参考文献19
-
1Varmns H. The new era in cancer research[J]. Sciencc,2006,312 (5777) : 1162 - 1165.
-
2Karakaa B. British [ J]. Cancer ,2006,94:455 - 459.
-
3DAVIES H, BIGNELL GR, COX C, et al. Mutations of the BRAF genv in human cancer[ J]. Nature,2002,417 (6892) :949 -954.
-
4Miikulam, Schriberm, Husakz, et al. Embryonic lethality and fetal liv- er apotoais in mice lacking the Craf- 1 genv[J]. EMBO J,2001,20 (8) :1952 -1962.
-
5Wang L,Cunningham JM,Winters JL,et al. BRAF mutations in clon cancer are not likely attributable to defective DNA mismatch re pair[ J]. Cancer Res,2003,63 (17) : 5209 - 5212.
-
6Oleveira C,Pinto M, Duval A, et al. BRAF mutations characterize co- lon but not gastric cancer with mismatch repair deficiency[ J]. On- cogene,2003,22(57) :9192 - 9196.
-
7Nagasaka T, Sasamoto H, Notohara K, et al. Colorectal cancer with mutation in BRAF, KRAS,and wild -type with respect to both on- cogenes showing different patterns of DNA methylation [J]. J Clin Oncol, 2004,22 ( 22 ) :4584 - 4594.
-
8Cart N J, Mahajan H, Tan KL, et al. Serrated and non - serrated 1901- yps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of ses- sile serrated adenoma[ J]. J Clin pathol,2009,12( 11 ) :27.
-
90'Brien MJ. Hyperplastic and serrated polyps of ghe colorectum [J]. Gastroenterol Clin north Am,2007,36(4) :945 -970.
-
10Yoshida S, Ikdhara N, Aoyama N. Relationship of BRAF mution, Morphology,and apoptosis in early colorectal cancer [J]. Int J Colorvctal Dis,2008,23 ( 1 ) :6 - 14.
二级参考文献35
-
1来茂德.结直肠锯齿状病变与癌[J].中华病理学杂志,2006,35(2):65-67. 被引量:17
-
2万德森.结直肠癌外科治疗若干热点问题[J].中华肿瘤防治杂志,2007,14(8):561-563. 被引量:23
-
3Varmus H.The new era in cancer research[J].Science,2006,312(5777):1162-1165.
-
4Dalton WS,Friend SH.Cancer biomarkers-an invitation to the table[J].Science,2006,312(5777):1165-1168.
-
5Hartman M,Loy EY,Ku CS,et al.Molecular epidemiology and its current clinical use in cancer management[J].Lancet Oncol,2010,11(4):383-390.
-
6Chari R,Thu KL,Wilson IM,et al.Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer[J].Cancer Metastasis Rev,2010,29(1):73-93.
-
7Dianat SS,Margreiter M,Eckersberger E,et al.Gene polymorphisms and prostate cancer:the evidence[J].BJU Int,2009,104(11):1560-1572.
-
8Amundadottir L,Kraft P,Stolzenberg-Solomon RZ,et al.Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer[J].Nat Genet,2009,41(9):986-990.
-
9Ashida R,Nakata B,Shigekawa M,et al.Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer[J].J Exp Clin Cancer Res,2009,28:83.
-
10Harada T,Chelala C,Crnogorac-Jurcevic T,et al.Genome-wide analysis of pancreatic cancer using microarray-based techniques[J].Pancreatology,2009,9(1-2):13-24.
共引文献19
-
1张大奎,李明.结直肠癌外科治疗进展[J].中国医学前沿杂志(电子版),2011,3(6):11-13. 被引量:2
-
2张大奎,李明.结直肠癌外科治疗进展[J].中国继续医学教育,2011,3(9):28-30. 被引量:2
-
3郭世奎,包维民,龚昆梅,邵剑春,陈弟,王昆华.SYBR GreenⅠ实时荧光定量PCR法分析结直肠癌患者肠道菌群变化[J].中国普外基础与临床杂志,2010,17(5):463-468. 被引量:15
-
4王辉,侯瑞,杨光,徐文林,吕申.BRAF在前列腺癌组织中的表达及意义[J].大连医科大学学报,2010,32(6):652-654.
-
5张惊涛.早期直肠癌的外科治疗[J].中国中医药现代远程教育,2011,9(5):177-177.
-
6Zhihong Wen,Xiaoli Zou,Guang Yang,Hui Wang.The expression and clinical significance of BRAF in prostate cancer[J].The Chinese-German Journal of Clinical Oncology,2011,10(9):523-525.
-
7陈超,禹立霞,魏嘉,孔炜伟,邹征云,韩成龙,钱晓萍,刘宝瑞.恶性浆膜腔积液TOPO-I表达与顺铂/羟基喜树碱灌注化疗疗效及预后关系[J].现代肿瘤医学,2012,20(1):154-158. 被引量:2
-
8郭双双,马文静,张立成,孙文俏.肿瘤患者个体化检测化疗的疗效观察[J].实用癌症杂志,2012,27(3):292-294. 被引量:1
-
9陈伟杰.直肠癌治疗进展[J].西部中医药,2012,25(7):127-128. 被引量:3
-
10甄运寰,颜登国,张东兴,李国胜,龚慧.人结直肠癌化疗药物的裸鼠体内敏感性实验[J].中国普外基础与临床杂志,2013,20(1):48-53. 被引量:1
同被引文献5
-
1涂金花,余英豪.基因突变与结直肠癌靶向治疗的新进展[J].世界华人消化杂志,2012,20(16):1447-1452. 被引量:5
-
2李森朋,张岫美,张芮.BRAF基因突变与肿瘤耐药[J].药学研究,2013,32(8):470-472. 被引量:8
-
3陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:882
-
4熊慧,张阿伟,范贵民,扈清云.K-RAS和DCC在直结肠癌中的表达及意义[J].黑龙江医药科学,2014,37(2):53-54. 被引量:7
-
5尹相林,展秀君,沈萍,王艳秋,王缘,李若男,张淑红,关宝生.人外周血DNA提取方法比较[J].黑龙江医药科学,2014,37(6):47-48. 被引量:4
-
1于海林.青年人大肠癌42例内镜诊断分析[J].中国厂矿医学,2008,21(6):708-708.
-
2马向东,王滨男,赵巍.右半结肠癌误诊30例分析[J].黑龙江医学,2007,31(4):315-315.
-
3吴梅娟,孙文勇.BRAF基因在甲状腺乳头状癌中的研究进展[J].中国肿瘤,2008,17(6):489-491. 被引量:4
-
4郑树.结直肠癌早期诊断生物标志物的应用研究[J].中国肿瘤临床,2012,29(18):1333-1336. 被引量:6
-
5周娟,黄小红,郭建雄.紫杉醇脂质体联合顺铂、5-氟脲嘧啶治疗晚期食管癌[J].实用临床医药杂志,2009,13(10):83-84. 被引量:17
-
6周孟强,朱辉,王居峰.草酸铂联合氟尿嘧啶和甲酰四氢叶酸治疗晚期大肠癌[J].中国煤炭工业医学杂志,2003,6(10):983-984. 被引量:1
-
7戴朝六,赵闯.小肝癌治疗方法的合理选择[J].腹部外科,2013(2):75-77. 被引量:1
-
8黄伟,吴高松.甲状腺癌相关BRAF基因研究的新进展[J].中国普通外科杂志,2010,19(5):559-563. 被引量:11
-
9邱远,杨桦.加速康复外科在结肠直肠癌病人围手术期营养支持中的应用[J].外科理论与实践,2016,21(1):32-36. 被引量:9
-
10孙丽珍,武美玲.奥沙利铂联合化疗治疗大肠癌的护理[J].中国美容医学,2012,21(11X):178-179. 被引量:2